A total of 34 medicines have been approved in the NLEM 2022, which is an upgrade of NLEM 2015.
Ivermectin, a medication used to treat parasitic roundworm infections, which was widely prescribed during the initial days of the COVID pandemic has been included in the list under antifilarial category.
Likewise, Meropenem, Cefuroxime, Phenoxymethyl penicillin, Procaine, Benzylpenicillin, Amikacin, Bedaquiline, Delamanid, Itraconazole, Mupirocin, Terbinafine, Valganciclovir, Lamivudine, Tenofovir (A) + Lamivudine (B) + Dolutegravir (C), Dolutegravir, Darunavir (A) + Ritonavir (B), Daclatasvir, Tenofovir Alafenamide Fumarate (TAF), Bendamustine Hydrochloride, Irinotecan HCI, Trihydrate, Lenalidomide, Leuprolide acetate, Dabigatran, Tenecteplase, Fludrocortisone, Ormeloxifene, Insulin Glargine, Teneligliptin, Rotavirus vaccine, Latanoprost, Buprenorphine, Buprenorphine (A) + Naloxone (B), Nicotine (for nicotine replacement therapy), Montelukast.